Inventor · disambiguated record
Huiping Guan
Also filed as: GUAN HUIPING · GUAN HUIPING AMY
22 granted patents·10 pending applications·346 citations·filing 2002–2021
95Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD9SUGEN INC8SYROS PHARMACEUTICALS INC4ASTRAZENECA AB2BIRDIE BIOPHARMACEUTICALS INC2
Top patents by PatentIndex Score
32 records- 0196US11053240B22-amino-quinoline derivativesBIRDIE BIOPHARMACEUTICALS INC·Filed 2018·Granted Jul 6, 2021·23 cites·34 claims
- 0296US9035063B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted May 19, 2015·55 cites·8 claims
- 0395US6777417B23-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitorsSUGEN INC·Filed 2002·Granted Aug 17, 2004·56 cites·4 claims
- 0494US8937071B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jan 20, 2015·59 cites·15 claims
- 0594US6653308B23-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitorsSUGEN INC·Filed 2002·Granted Nov 25, 2003·75 cites·40 claims
- 0690US7186832B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Mar 6, 2007·32 cites·4 claims
- 0783US9918974B2Pyridone derivatives as rearranged during transfection (RET) kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Mar 20, 2018·3 cites·19 claims
- 0882US7256189B23-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitorsUPJOHN CO·Filed 2006·Granted Aug 14, 2007·4 cites·2 claims
- 0979US7179910B23-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitorsAGOURON PHARMA·Filed 2003·Granted Feb 20, 2007·10 cites·13 claims
- 1079US6642232B23-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitorsSUGEN INC·Filed 2002·Granted Nov 4, 2003·13 cites·25 claims
- 1177US10292975B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted May 21, 2019·1 cites·8 claims
- 1277US10111866B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Oct 30, 2018·1 cites·4 claims
- 1377US8088784B24-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancerFENG XIAOMEI·Filed 2010·Granted Jan 3, 2012·4 cites·6 claims
- 1477US7157460B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Jan 2, 2007·8 cites·4 claims
- 1569US10709695B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Jul 14, 2020·0 cites·15 claims
- 1669US9879021B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Jan 30, 2018·1 cites·20 claims
- 1764US11834448B22-amino-quinoline derivativesBIRDIE BIOPHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·0 cites·44 claims
- 1863US9868737B2Pyridino[1,2-A]pyrimidone analogue used as MTOR/P13K inhibitorCISEN PHARMACEUTICAL CO LTD·Filed 2015·Granted Jan 16, 2018·1 cites·8 claims
- 1963US7582756B23-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitorsSUGEN INC·Filed 2007·Granted Sep 1, 2009·0 cites·3 claims
- 2057US2010204231A1Amino-thiazolyl-pyrimidine derivatives and their use for the treatment of cancerASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2157US2021147431A1Pyrrolotriazine compounds and methods of inhibiting tam kinasesSYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2254US10294236B2Compounds as rearranged during transfection (RET) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted May 21, 2019·0 cites·19 claims
- 2354US2008287475A14-(3-Aminopyrazole) Pyrimidine Derivatives for Use as Tyrosine Kinase Inhibitors in the Treatment of CancerASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2452US11040981B2Pyrrolotriazine compounds and methods of inhibiting TAM kinasesSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·0 cites·28 claims
- 2549US2023145793A1Substituted pyrimidine or pyridine amine derivative, composition thereof, and medical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 2649US2004266855A13-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitorsSUGEN INC·Filed 2004·Application pending·0 cites
- 2747US2012071480A14-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancerFENG XIAOMEI·Filed 2011·Application pending·0 cites
- 2847US2021386721A1Substituted phenylpropenyl pyridine derivatives, their preparation and pharmaceutical applicationsSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 2945US11773078B2Furin inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 3, 2023·0 cites·22 claims
- 3044US2020071326A1Tam kinase inhibitorsSYROS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3141US2020291018A1Tam kinase inhibitorsSYROS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3237US2007293484A1Thiophene Heteroaryl AminesSUGEN INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Huiping Guan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →